Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis
Abstract
Multiple sclerosis is an inflammatory, neurodegenerative disease of the central nervous system for which therapeutic mesenchymal stem cell transplantation is under study. Published experience of culture-expanding multiple sclerosis patients’ mesenchymal stem cells for clinical trials is limited.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2018
- Source ID
- 10.1177/2055217318765288
Entities
People
- Basabi Maitra
- Brittney M Hooper
- Hillard M Lazarus
- Jane Reese Koc
- Jeffrey A Cohen
- Karen T Lingas
- Kylie M Drake
- Micheala A Aldred
- Peter B Imrey
- Robert M. Fox
- Sarah M Planchon
Organizations
- Case Western Reserve University
- Genomic Medicine Institute
- National Institute of Neurological Disorders and Stroke
- National Multiple Sclerosis Society
- United States Department of Defense